Results 221 to 230 of about 34,684 (258)
Some of the next articles are maybe not open access.

Lymphocytes, Lymphokines, and Silicosis

Journal of Environmental Pathology, Toxicology and Oncology, 2001
Silicosis is characterized by mononuclear cell aggregation with mineral particles and fibrosis. Lymphocytes are abundant in these lesions. We exposed inbred strains of mice to a respirable aerosol of cristobalite silica (70 mg/m3, 5 h/d, 12 d) or shamair. Silicosis evolved over months after exposure.
Linda M. Pfeiffer   +3 more
openaire   +2 more sources

Lymphokines and monokines in the clinic

Immunology Today, 1986
There has been a remarkable increase in understanding of the control of immune reactions and hemopoietic stem cell proliferation by cytokines. At a recent meeting(∗) investigators engaged in basic research, clinicians, and representatives of bioengineering and pharmaceutical companies gathered to discuss the present state and future potential of ...
Erich Platter   +3 more
openaire   +3 more sources

LYMPHOKINES IN RHEUMATOID SYNOVITIS

Annals of the New York Academy of Sciences, 1975
In antigen-induced experimental arthritis of rabbits, a macrophage migration inhibitory factor was released from the inflamed synovial tissues. A migration inhibitory factor, blastogenic factor, and B-cell-stimulating factor were also found in human rheumatoid synovial fluids and culture supernatants of rheumatoid tissue explants.
M. Rosenthal   +4 more
openaire   +3 more sources

Measurement of Lymphokine Receptors

Current Protocols in Immunology, 2000
AbstractOne of the most widely studied lymphokine systems is the T lymphocyte growth factor interleukin 2 (IL‐2). This unit describes two basic methods for the quantitation and biochemical characterization of IL‐2 receptors. The first method employs the radioreceptor assay.
John W. Lowenthal   +2 more
openaire   +3 more sources

Immunotherapy of cancer with lymphokines and lymphokine‐activated killer cells

Seminars in Surgical Oncology, 1991
AbstractOur expanding knowledge of the immune system has provided a basis of rationality for immunotherapy. Some non‐specific immunotherapy has achieved the status of standard treatment: interferon in hairy cell leukemia and chronic myelogenous leukemia, BCG in bladder cancer, and levamisole in colon cancer adjuvant therapy.
openaire   +3 more sources

Lymphokines and cytokines.

Cancer chemotherapy and biological response modifiers, 1990
The area of lymphokines and cytokines is expanding at an enormous rate. Already the clinical value of the rDNA interferons is becoming more clearly defined. Interleukin-2 holds considerable therapeutic promise, but toxicity is a serious problem with this agent.
J, Wagstaff, K, Melief
openaire   +5 more sources

Prostaglandins and Lymphokines in Inflammation

Rheumatology, 1978
It is suggested that the inflammatory process in rheumatoid arthritis (RA) results from activation of small lymphocytes to produce lymphokines, whose biological properties are appropriate to a mediator of chronic inflammation. Since prostaglandins (PGs) and allied products of arachidonic acid metabolism have properties pertinent to chronic inflammation,
openaire   +3 more sources

Lymphokines and Monokines

1993
The cellular parts of the immune system (macrophages, T cells, and B cells) are regulated in their functions, to a large extent, by factors produced by these cells. These factors produced by the cells of the immune system are referred to as cytokines in the generic sense.
Nicholas P. Plotnikoff   +1 more
openaire   +2 more sources

Lymphokine receptor interactions

Immunology Today, 1989
The VI International Lymphokine Workshop, focused on lymphokine receptor interactions and as expected, a large body of new information was released during this meeting. The molecular characterization of several new cytokines and preliminary characterization of their biological effects was reported and new biological activities of known cytokines were ...
openaire   +3 more sources

On Lymphokines, Cytokines, and Breakthroughs

JAMA: The Journal of the American Medical Association, 1986
Advanced cancer will take the lives of almost half a million Americans this year. Certainly, any claim of therapeutic accomplishment in this area will attract major public interest. In recent times, this interest has been focused on the lymphokines and cytokines, natural substances that man produces as a defense against the diseases that may afflict ...
openaire   +3 more sources

Home - About - Disclaimer - Privacy